CTAD: Revived Alzheimer’s symptomatic drug set to test as donepezil combo

BARCELONA – RVT-101, a novel small molecule that increases acetylcholine release, is poised for what its developers say could be its pivotal trial for U.S. approval.

The MINDSET study will examine...